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Introduction & Objectives: In active surveillance (AS) management, there are controversies for the different pathological progression (PP) criteria
from prostate cancer (PCa) GGI (Gleason 3+3). Our objective is to know if PP just in tumoral volumen is irrelevant vs PP in grade.
Materials & Methods: We select for our study AS patients registered in AEU/PIEM/2014/0001 with GGI and analyze different types of PP; in grade
(increase to ≥ GG2 PCa), in volume with previously defined criteria for such (https://piem.aeu.es/proyectos/VACP/Gestor.aspx) and grade+volume.
We just include patients that went on radical prostatectomy after progression and consider final pathological report to analyze increase in grade
and/or ≥pT3a, Epstein (≥GG2+/-pT3a+/-pN1+/- tumoral volumen >0.5cc) and Wolter´s criteria (same but >1.3cc in index lesion or >2.5cc summing
all PCa foci) to define pathological aggressivenes of the tumour.
Results: 1592 out of 2289 registered patients on AS had GGI PCa and follow-up biopsies; 651 of these (41.01%) has PP with a median follow-
up of 2 years. PP just in volume was present in 289 patients (18.2%), exclusively in grade in 96 (6%) and in both in 268 (16.9%). Those figures
correspond to 44.3%, 14.7% and 41% of all the PP.
N = 374 radical prostatectomies Aggressive Pat NO Aggressive Pat YES
123 (32.9 %) 251 (67.1 %)
Without PP (RP for anxiety), N=71 36 (50.7%) 35 (49.3%)
PP just in tumoral volumen N=114 66 (57.9%) 48 (42.1%)
PP just in grade N=49 10 (20.4%) 39 (79.6%)
PP in volumen and grade N=140 11 (7.9%) 129 (92.1%)
If we focus on Epstein criteria, PP just in tumoral volum shows 89% of significant PCa in RP specimen and following Wolter´s criteria that figure
decrease to 76.7%.
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We found no significant statistical differences between PP just in tumoral volume compared to specimens derived from radical prostatectomies
done as per patient anxiety with any of the 3 different pathological criteria por PCa aggressiveness
Conclusions: 1.Relevance of PP just in tumoral volume is questionable.
2.Pathological progression exclusively in tumoral volume is not different from the observed in radical prostatectomies performed after patient desire
due to anxiety with no progression in FU biopsies.
3.Relevance of such PP just in tumoral volume will be dictated by biochemical progression free survival splitted by type of pathological progression,
not valuable in our Register yet due to short FU.
4.Until longer FU, in front of a PP just in tumoral volumen, every case has to be individualized together with other predictive variables such as age,
PSAd, tumoral load in the FU biopsy and mpMRI data to stay in AS or move to active treatment.
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